Sitagliptin for the Treatment of Type 2 Diabetes
NCT04495881
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Sitagliptin 100mg
Sponsor
Beijing Chao Yang Hospital